A Multicenter, Randomized, Double-Blind, Crossover Study to Compare the Safety and Efficacy of Ultrase MT20 to Placebo for the Correction of Steatorrhea in Patients with Cystic Fibrosis

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/0712/31/08

Funding

  • Axcan Pharma Inc.: $64,144.00